Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
Clinical trial NCT02506959 · COMPLETED
Trial details
- NCT number
- NCT02506959
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-14
- Primary completion
- 2024-06-03
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.